Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

11

Number of overlapping holdings

36.7%

% of MEDX's 30 holdings also in XLV

17.5%

% of XLV's 64 holdings also in MEDX

Overlap by Weight
Sector Drift (MEDX minus XLV)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in XLV
Overlap
ELI LILLY & CO 14.9% 11.2% 11.2%
ABBVIE INC 7.8% 5.7% 5.7%
JOHNSON & JOHNSON 5.2% 6.9% 5.2%
MERCK & CO. INC. 5.2% 6.2% 5.2%
PFIZER INC 4.1% 2.9% 2.9%

Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to XLV
NOVARTIS AG-ADR 5.5%
ASTRAZENECA PLC-SPONS ADR 5.2%
ELI LILLY & CO 3.7%
CRISPR THERAPEUTICS AG 3.6%
BRISTOL-MYERS SQUIBB CO 3.4%
ALKERMES PLC 3.4%
BIOGEN IDEC INC 3.2%
IONIS PHARMACEUTICALS, INC. 3.1%
GLAXOSMITHKLINE PLC-SPON ADR 2.7%
AMGEN INC 2.7%
MEDX Underweight Relative to XLV
UNITEDHEALTH GROUP INC -9.0%
THERMO FISHER SCIENTIFIC INC -4.1%
ABBOTT LABORATORIES -3.6%
DANAHER CORP -3.0%
INTUITIVE SURGICAL INC -2.5%
ELEVANCE HEALTH INC -2.4%
STRYKER CORP -2.1%
MEDTRONIC PLC -2.1%
CIGNA CORPORATION -2.0%
VERTEX PHARMACEUTICALS INC -2.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY